Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,586 | -2,968 | -1,982 | -971 | -5,087 |
| Accounts payable and accrued liabilities | -74 | -91 | -25 | 90 | -74 |
| Other Working Capital | 3 | 62 | 7 | 79 | -48 |
| Other Operating Activity | 492 | 431 | 392 | 13 | 916 |
| Operating Cash Flow | $-3,165 | $-2,566 | $-1,608 | $-789 | $-4,293 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 3,143 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $3,143 |
| Beginning Cash Position | 4,204 | 4,204 | 4,204 | 4,204 | 5,353 |
| End Cash Position | 1,039 | 1,638 | 2,595 | 3,414 | 4,204 |
| Net Cash Flow | $-3,165 | $-2,566 | $-1,608 | $-789 | $-1,150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,165 | -2,566 | -1,608 | -789 | -4,293 |
| Free Cash Flow | -3,165 | -2,566 | -1,608 | -789 | -4,293 |